Governors Lane’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-490,000
Closed -$5.11M 92
2023
Q1
$5.11M Hold
490,000
0.65% 45
2022
Q4
$5.02M Hold
490,000
0.52% 64
2022
Q3
$4.92M Hold
490,000
0.42% 74
2022
Q2
$4.88M Hold
490,000
0.39% 82
2022
Q1
$4.88M Buy
+490,000
New +$4.86M 0.35% 88

Governors Lane's LVAC Position: Q2 2023 in Review

Governors Lane sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q2 2023, closing a stake of 490,000 shares — an estimated $5.11M sold.

Governors Lane first reported a position in LVAC in Q1 2022 and held it in 5 quarters. The position peaked at $5.11M in Q1 2023. 0 funds tracked by Wall St. Rank hold LVAC as of Q2 2023.

  • Governors Lane reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • Governors Lane sold 490,000 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $5.11M.
  • Governors Lane first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 5 quarters.
  • Governors Lane's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $5.11M in Q1 2023.
  • 0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Governors Lane's 13F filing for Q2 2023, filed 14 Aug 2023.